OTC: NWBO - Northwest Biotherapeutics, Inc.

六个月盈利: -34.79%
股息率: 0.00%
部门: Healthcare

促销时间表 Northwest Biotherapeutics, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors.

更多详情
The company was founded in 1996 and is headquartered in Bethesda, Maryland.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

ISIN US66737P6007
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.nwbio.com
Цена ао 0.53
每日价格变化: +1.44% (0.27)
每周价格变化: +5.35% (0.26)
每月价格变化: -2.18% (0.28)
3个月内价格变化: -14.41% (0.32)
六个月内的价格变化: -34.79% (0.42)
每年价格变化: -60.87% (0.7)
3年内价格变化: -59.72% (0.68)
5年内价格变化: +21.73% (0.225)
10年价格变化: 0% (0.2739)
年初以来价格变化: -8.7% (0.3)
所有参数

低估

姓名 意义 年级
P/S 456.31 1
P/BV -13.4 0
P/E 0 0
EV/EBITDA -9.03 0
全部的: 2

效率

姓名 意义 年级
ROA, % -224.65 0
ROE, % 95.17 10
全部的: 1.67

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.4184 10
全部的: 9.6

成长冲动

姓名 意义 年级
盈利能力 Revenue, % -19.5 0
盈利能力 Ebitda, % 296.2 10
盈利能力 EPS, % 61.38 8
全部的: 7.2
更多详情

机构 体积 分享, %
Moloney Securities Asset Management, LLC 358160 0.03
Opus Capital Group, LLC 60150 0.01
Williams Jones Wealth Management, LLC. 44000 0
Lee, Danner & Bass, Inc. 20000 0
MAI Capital Management 20000 0
Advisors Management Group, Inc. 10270 0
Bartlett & Co. 4292 0
Bartlett & Co. Wealth Management LLC 4292 0
Coston, McIsaac & Partners 1000 0



导师 职称 支付 出生年份
Ms. Linda F. Powers J.D. Chairperson, CEO, President, CFO & Chief Accounting Officer 925k 1956 (69 年)
Dr. Alton L. Boynton Ph.D. Founder, Chief Scientific Officer, Secretary & Director 375k 1945 (80 年)
Dr. Marnix L. Bosch M.B.A., Ph.D. Chief Technical Officer 453.6k 1959 (66 年)
Mr. Leslie J. Goldman Senior VP & General Counsel 725k 1945 (80 年)
Mr. David Innes Vice President of Investor Relations N/A

地址: United States, Bethesda. MD, 4800 Montgomery Lane - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.nwbio.com